Investor Presentaiton slide image

Investor Presentaiton

Business Snapshot LAURUS Generics - API Active Pharmaceutical Ingredients & Intermediates Overview • Development, manufacture and sale of APIs and Advanced Intermediates Leadership in various High Value and High Volume APIs with sizeable Global Market share. High potent manufacturing capability in Five manufacturing units. . LAURUS Generics -FDF Finished Dosage Forms Developing and manufacturing oral solid formulations for LMIC, North America & EU Markets. Backed by in house API strengths . LAURUS Synthesis Contract Development & Manufacturing Services Contract development and manufacturing services for global pharmaceutical companies and several late stage projects executed Steroids and Hormone manufacturing capability Sale and manufacture of specialty ingredients for use in nutraceuticals, dietary supplements and cosmeceutical products with natural extraction capability Product and Service Offerings Filings • Infrastructure • Anti-Viral • Anti-diabetic • CVS • PPls • Oncology Commercialized 60+ products • 61 DMFS filed • 4 Manufacturing facilities, (3,425 KL) (1) (2) ~1,000 KL under expansion (1) Includes ingredients products excluding Unit 2 API & Kilo lab capacity Anti-Viral Anti-diabetic • CVS PPls CNS Filed 26 ANDAS with USFDA and 8 Final approvals and 8 tentative approvals In addition completed 2 products validation • Field 12 dossiers in Canada, 9 in Europe, 8 with WHO, 2 in South Africa, 2 in India & 12 products filed in various ROW markets. 5 bn Units/year capacity Capacity enhancement under progress . (2) APIs, Ingredients and Synthesis (other than Aspen supplies) are manufactured at Unit 1,3,4 & 6 Commercial scale contract manufacturing Clinical phase supplies • Analytical and research services . Nutraceuticals, dietary supplements and cosmeceutical products API validation planned in Unit 05 Custom development of ophthalmic portfolio initiated Dedicated manufacturing (Unit - 5) Capacity (137 KL) for steroidal and hormonal intermediates Set up a dedicated block in Unit 4 for high potent phytochemicals APIs Incorporated Laurus Synthesis Pvt. Ltd (LSPL) Capacity (149 KL) 4 LAURUS Labs Knowledge Innovation. Excelence
View entire presentation